Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Patel Samir Rashmikant
Over the trailing 90 days, Patel Samir Rashmikant (Director at Akari Therapeutics Plc) bought $392K of stock in AKTX, per 6 SEC Form 4 transactions.
- Role
- Director
- Companies
- AKTX
- Window
- Trailing 90 days · 6 transactions · CIK 1702447
- Net activity
- +$392K ($392K bought · $0 sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| AKTX | Akari Therapeutics Plc | 6 | $392K | — | $392K |
Transactions (6)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-07 | AKTX | Buy | 15.5K | $6 | Exercise or conversion of derivative security |
| 2026-07-07 | AKTX | Buy | 1.2K | $10K | Exercise or conversion of derivative security |
| 2026-07-07 | AKTX | Buy | 5.8K | $2 | Exercise or conversion of derivative security |
| 2026-07-07 | AKTX | Buy | 5.8K | $94K | Exercise or conversion of derivative security |
| 2026-07-07 | AKTX | Buy | 1.2K | $39K | Exercise or conversion of derivative security |
| 2026-07-07 | AKTX | Buy | 15.5K | $250K | Exercise or conversion of derivative security |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Patel's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.